ZA949647B - C5a receptor antagonists having substantially no agonist activity - Google Patents
C5a receptor antagonists having substantially no agonist activityInfo
- Publication number
- ZA949647B ZA949647B ZA949647A ZA949647A ZA949647B ZA 949647 B ZA949647 B ZA 949647B ZA 949647 A ZA949647 A ZA 949647A ZA 949647 A ZA949647 A ZA 949647A ZA 949647 B ZA949647 B ZA 949647B
- Authority
- ZA
- South Africa
- Prior art keywords
- receptor antagonists
- agonist activity
- agonist
- activity
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16259193A | 1993-12-06 | 1993-12-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA949647B true ZA949647B (en) | 1995-06-06 |
Family
ID=22586301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA949647A ZA949647B (en) | 1993-12-06 | 1994-12-05 | C5a receptor antagonists having substantially no agonist activity |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0733107A1 (xx) |
JP (1) | JPH09506258A (xx) |
CN (1) | CN1142854A (xx) |
AU (1) | AU698919B2 (xx) |
BR (1) | BR9408265A (xx) |
CA (1) | CA2176825A1 (xx) |
FI (1) | FI962319A (xx) |
HU (1) | HUT75990A (xx) |
IL (1) | IL111792A0 (xx) |
MX (1) | MXPA99008669A (xx) |
NO (1) | NO962348L (xx) |
NZ (1) | NZ274917A (xx) |
TW (1) | TW429262B (xx) |
WO (1) | WO1995016033A1 (xx) |
ZA (1) | ZA949647B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837499A (en) * | 1993-12-06 | 1998-11-17 | Ciba-Geigy Corporation | DNA encoding C5A receptor antagonists having substantially no agonist activity and methods of expressing same |
EP0832223A1 (en) * | 1995-06-05 | 1998-04-01 | Novartis AG | C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION |
BR9607139A (pt) * | 1995-12-13 | 1997-11-25 | Northern Telecom Ltd | Sistemas de telecomunicações de dados com pacote digital e voz celular integrado e processos para sua operação |
AUPO755097A0 (en) | 1997-06-25 | 1997-07-17 | University Of Queensland, The | Receptor agonist and antagonist |
TWI767415B (zh) * | 2020-11-18 | 2022-06-11 | 中國醫藥大學 | 自動化血液分析系統及自動化血液分析方法 |
CN113150106B (zh) * | 2021-04-26 | 2022-08-16 | 华中农业大学 | 来源于补体成分C5a的抗菌肽及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0305615A1 (en) * | 1987-09-03 | 1989-03-08 | Immunetech Pharmaceuticals, Inc. | Peptide antagonists for the C5a anaphylatoxin |
DE3785967T2 (de) * | 1986-04-28 | 1993-12-02 | Cetus Corp | Monoklonale Antikörper gegen C5A und DES-ARG74-C5A, ihre Herstellung und ihre Verwendung. |
-
1994
- 1994-11-16 CA CA002176825A patent/CA2176825A1/en not_active Abandoned
- 1994-11-16 HU HU9601538A patent/HUT75990A/hu unknown
- 1994-11-16 EP EP94931155A patent/EP0733107A1/en not_active Withdrawn
- 1994-11-16 JP JP7516068A patent/JPH09506258A/ja active Pending
- 1994-11-16 BR BR9408265A patent/BR9408265A/pt not_active Application Discontinuation
- 1994-11-16 CN CN94194914A patent/CN1142854A/zh active Pending
- 1994-11-16 WO PCT/IB1994/000359 patent/WO1995016033A1/en not_active Application Discontinuation
- 1994-11-16 NZ NZ274917A patent/NZ274917A/en unknown
- 1994-11-16 AU AU80025/94A patent/AU698919B2/en not_active Ceased
- 1994-11-28 IL IL11179294A patent/IL111792A0/xx unknown
- 1994-12-05 ZA ZA949647A patent/ZA949647B/xx unknown
- 1994-12-13 TW TW083111578A patent/TW429262B/zh not_active IP Right Cessation
-
1996
- 1996-06-03 FI FI962319A patent/FI962319A/fi unknown
- 1996-06-05 NO NO962348A patent/NO962348L/no not_active Application Discontinuation
-
1999
- 1999-09-21 MX MXPA99008669A patent/MXPA99008669A/es unknown
Also Published As
Publication number | Publication date |
---|---|
NO962348D0 (no) | 1996-06-05 |
FI962319A0 (fi) | 1996-06-03 |
BR9408265A (pt) | 1996-12-10 |
HUT75990A (en) | 1997-05-28 |
NZ274917A (en) | 1998-03-25 |
FI962319A (fi) | 1996-06-03 |
CN1142854A (zh) | 1997-02-12 |
CA2176825A1 (en) | 1995-06-15 |
AU8002594A (en) | 1995-06-27 |
MXPA99008669A (es) | 2004-09-01 |
IL111792A0 (en) | 1995-01-24 |
HU9601538D0 (en) | 1996-07-29 |
NO962348L (no) | 1996-08-05 |
WO1995016033A1 (en) | 1995-06-15 |
TW429262B (en) | 2001-04-11 |
EP0733107A1 (en) | 1996-09-25 |
AU698919B2 (en) | 1998-11-12 |
JPH09506258A (ja) | 1997-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0767792A4 (en) | VITRONECTIN RECEPTOR ANTAGONISTS | |
ZA955391B (en) | Vitronectin receptor antagonists | |
CY2576B1 (en) | Vitronectin receptor antagonists | |
IL125030A0 (en) | Vitronectin receptor antagonists | |
HUP9900754A3 (en) | Vitronectin receptor antagonists | |
IL125034A0 (en) | Vitronectin receptor antagonists | |
HU9601529D0 (en) | Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists | |
GB9405317D0 (en) | Fibrinogen receptor antagonists | |
EP0673247A4 (en) | FIBRINOGEN RECEPTOR ANTAGONISTS. | |
EP0667773A4 (en) | FIBRINOGEN RECEPTOR ANTAGONISTS. | |
ZA948541B (en) | Endothelin receptor antagonists | |
EP0810994A4 (en) | FIBRINOGENIC RECEPTOR ANTAGONISTS | |
HU913074D0 (en) | Fibrinogenic receptor antagonists | |
EP0866705A4 (en) | FIBRINOGENIC RECEPTOR ANTAGONISTS | |
HU9501931D0 (en) | Endothelin receptor antagonists | |
EP0796098A4 (en) | FIBRINOGEN RECEPTOR ANTAGONISTS | |
HU9502028D0 (en) | Fibrinogen receptor antagonists | |
GB9320799D0 (en) | Fibrinogen receptor antagonists | |
EP0794779A4 (en) | FIBRINOGENIC RECEPTOR ANTAGONISTS | |
IL111792A0 (en) | C5a receptor antagonists having substantially no agonist activity | |
AU6125096A (en) | C5a receptor antagonists having substantially no agonist activity and methods for preparation | |
EP0711157A4 (en) | ENDOTHELIN RECEPTOR ANTAGONISTS | |
EP0781133A4 (en) | FIBRINOGENIC RECEPTOR ANTAGONISTS | |
ZA964586B (en) | C5a receptor antagonists having substantially no agonist activity and methods for preparation | |
ZA968939B (en) | Fibrinogen receptor antagonist |